These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 19399016)

  • 21. Ruminant and industrial trans-fatty acids consumption and cardiometabolic risk markers: A systematic review.
    Verneque BJF; Machado AM; de Abreu Silva L; Lopes ACS; Duarte CK
    Crit Rev Food Sci Nutr; 2022; 62(8):2050-2060. PubMed ID: 33081490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Replacing trans fat: the argument for palm oil with a cautionary note on interesterification.
    Hayes KC; Pronczuk A
    J Am Coll Nutr; 2010 Jun; 29(3 Suppl):253S-284S. PubMed ID: 20823487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trans fatty acids and lipid profile: A serious risk factor to cardiovascular disease, cancer and diabetes.
    Islam MA; Amin MN; Siddiqui SA; Hossain MP; Sultana F; Kabir MR
    Diabetes Metab Syndr; 2019; 13(2):1643-1647. PubMed ID: 31336535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trans fatty acids linked to myocardial infarction and stroke: What is the evidence?
    Shah B; Thadani U
    Trends Cardiovasc Med; 2019 Jul; 29(5):306-310. PubMed ID: 31130187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. trans-Fatty Acids as an Enhancer of Inflammation and Cell Death: Molecular Basis for Their Pathological Actions.
    Hirata Y
    Biol Pharm Bull; 2021; 44(10):1349-1356. PubMed ID: 34602541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On account of trans fatty acids and cardiovascular disease risk - There is still need to upgrade the knowledge and educate consumers.
    Niforou A; Magriplis E; Klinaki E; Niforou K; Naska A
    Nutr Metab Cardiovasc Dis; 2022 Aug; 32(8):1811-1818. PubMed ID: 35753860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Industrial
    Takeuchi H; Sugano M
    J Lipids; 2017; 2017():9751756. PubMed ID: 28951788
    [No Abstract]   [Full Text] [Related]  

  • 28. Understanding the complexities of prevalence of trans fat and its control in food supply in Pakistan.
    Tarar OM; Ahmed KM; Nishtar NA; Achakzai ABK; Gulzar Y; Delles C; Al-Jawaldeh A
    J Clin Hypertens (Greenwich); 2020 Aug; 22(8):1338-1346. PubMed ID: 32687252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of recommending certain replacement or alternative fats.
    Skeaff CM
    Eur J Clin Nutr; 2009 May; 63 Suppl 2():S34-49. PubMed ID: 19424217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dietary Ruminant and Industrial Trans-Fatty Acids Intake and Colorectal Cancer Risk.
    Seyyedsalehi MS; Collatuzzo G; Rashidian H; Hadji M; Gholipour M; Mohebbi E; Kamangar F; Pukkala E; Huybrechts I; Gunter MJ; Chajes V; Boffetta P; Zendehdel K
    Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trans fatty acids - effects on systemic inflammation and endothelial function.
    Mozaffarian D
    Atheroscler Suppl; 2006 May; 7(2):29-32. PubMed ID: 16713393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overview of trans fatty acids: biochemistry and health effects.
    Bhardwaj S; Passi SJ; Misra A
    Diabetes Metab Syndr; 2011; 5(3):161-4. PubMed ID: 22813572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: role of dietary fats and oils.
    Misra A; Singhal N; Khurana L
    J Am Coll Nutr; 2010 Jun; 29(3 Suppl):289S-301S. PubMed ID: 20823489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the Complexities of Eliminating Trans Fatty Acids: The Case of the Trans Fatty Acid Ban in Thailand.
    Samsiripong W; Phulkerd S; Pattaravanich U; Kanchanachitra M
    Nutrients; 2022 Jul; 14(13):. PubMed ID: 35807928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different Types of Industry-Produced and Ruminant Trans Fatty Acid Intake and Risk of Type 2 Diabetes: Findings From the NutriNet-Santé Prospective Cohort.
    Wendeu-Foyet G; Bellicha A; Chajès V; Huybrechts I; Bard JM; Debras C; Srour B; Sellem L; Fezeu LK; Julia C; Kesse-Guyot E; Agaësse C; Druesne-Pecollo N; Galan P; Hercberg S; Deschasaux-Tanguy M; Touvier M
    Diabetes Care; 2023 Feb; 46(2):321-330. PubMed ID: 36542554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trans fatty acids and weight gain.
    Thompson AK; Minihane AM; Williams CM
    Int J Obes (Lond); 2011 Mar; 35(3):315-24. PubMed ID: 20644558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of dietary saturated and trans-fatty acids on expression of genes associated with insulin sensitivity in rat adipose tissue.
    Saravanan N; Haseeb A; Ehtesham NZ; Ghafoorunissa
    Eur J Endocrinol; 2005 Jul; 153(1):159-65. PubMed ID: 15998628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma Industrial and Ruminant Trans Fatty Acids and Incident Type 2 Diabetes in the EPIC-Potsdam Cohort.
    Prada M; Wittenbecher C; Eichelmann F; Wernitz A; Kuxhaus O; Kröger J; Weikert C; Schulze MB
    Diabetes Care; 2022 Apr; 45(4):845-853. PubMed ID: 35129607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trans fatty acids, insulin resistance, and type 2 diabetes.
    Odegaard AO; Pereira MA
    Nutr Rev; 2006 Aug; 64(8):364-72. PubMed ID: 16958313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipotoxicity: effects of dietary saturated and transfatty acids.
    Estadella D; da Penha Oller do Nascimento CM; Oyama LM; Ribeiro EB; Dâmaso AR; de Piano A
    Mediators Inflamm; 2013; 2013():137579. PubMed ID: 23509418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.